By contrast, AAT therapy seems to be very effective in those AAT-deficient patients suffering from panniculitis, vasculitis, and asthma (5, 6), suggesting that AAT-mediated anti-inflammatory effects are most important. This evidence concerns the gene SERPINA1 and vasculitis.